FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023573903> ?p ?o ?g. }

• W2023573903 endingPage "762" @default.
• W2023573903 startingPage "753" @default.
• W2023573903 abstract "SN 28049 (N-[2-(dimethylamino)ethyl]-2,6-dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide) is a DNA intercalating drug that binds selectively to GC-rich DNA and shows curative activity against the Colon 38 adenocarcinoma in mice. We wished to investigate the roles of topoisomerase (topo) I, topo II and RNA transcription in the action of SN 28049.We used clonogenic assays to study the cytotoxicity of SN 28049; RNA interference and enzyme assays to examine the role of topo I in SN 28049 action; 3H uridine incorporation and reporter assays to study its effects on transcription; and RT-PCR to examine its ability to reduce endogenous h-TERT expression.In clonogenic assays, SN 28049 showed a biphasic cytotoxic dose response curve in H460 cells typical of acridine derivatives such as N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) although it was approximately 16-fold more potent. Down-regulation of topo IIalpha in HTETOP cells reduced the cytotoxicity of SN 28049, establishing its action as a topo IIalpha poison. Surprisingly, down-regulation of topo I in H460 cells by RNA interference sensitised them to the actions of SN 28049 and other topo II poisons. SN 28049 also inhibited topo I-mediated relaxation of supercoiled plasmid DNA. SN 28049 was also an inhibitor of transcription in HEK293 cells and was more potent at reducing luciferase expression from a GC-rich SP-1 binding promoter than from a non-GC-rich AP-1 binding promoter. The drug also reduced luciferase reporter gene expression driven by the SP-1-binding survivin promoter as well as reducing endogenous h-TERT expression in HEK293 cells whose promoter also contains SP-1 binding sites.We conclude that SN 28049 has a complex action that may involve poisoning of topo IIalpha, suppression of topo I and inhibition of gene transcription from promoters with SP-1 sites. These actions may contribute to the promising experimental solid tumour anticancer activity of SN 28049." @default.
• W2023573903 created "2016-06-24" @default.
• W2023573903 creator A5014826195 @default.
• W2023573903 creator A5027648939 @default.
• W2023573903 creator A5031189811 @default.
• W2023573903 creator A5061684371 @default.
• W2023573903 date "2008-01-03" @default.
• W2023573903 modified "2023-09-27" @default.
• W2023573903 title "The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049" @default.
• W2023573903 cites W1586111039 @default.
• W2023573903 cites W1964639478 @default.
• W2023573903 cites W1969528530 @default.
• W2023573903 cites W1977415453 @default.
• W2023573903 cites W1979403925 @default.
• W2023573903 cites W1979501769 @default.
• W2023573903 cites W1980782542 @default.
• W2023573903 cites W1982698061 @default.
• W2023573903 cites W1994789711 @default.
• W2023573903 cites W1995968418 @default.
• W2023573903 cites W2003226308 @default.
• W2023573903 cites W2005277368 @default.
• W2023573903 cites W2021043660 @default.
• W2023573903 cites W2022631908 @default.
• W2023573903 cites W2025023091 @default.
• W2023573903 cites W2030820821 @default.
• W2023573903 cites W2034660754 @default.
• W2023573903 cites W2037587486 @default.
• W2023573903 cites W2050854335 @default.
• W2023573903 cites W2064436859 @default.
• W2023573903 cites W2070498380 @default.
• W2023573903 cites W2074469807 @default.
• W2023573903 cites W2077054904 @default.
• W2023573903 cites W2079906926 @default.
• W2023573903 cites W2080566980 @default.
• W2023573903 cites W2084378161 @default.
• W2023573903 cites W2084971869 @default.
• W2023573903 cites W2090637879 @default.
• W2023573903 cites W2103625519 @default.
• W2023573903 cites W2113685363 @default.
• W2023573903 cites W2122317160 @default.
• W2023573903 cites W2124624490 @default.
• W2023573903 cites W2129874997 @default.
• W2023573903 cites W2132600317 @default.
• W2023573903 cites W2136946165 @default.
• W2023573903 cites W2151753662 @default.
• W2023573903 cites W2160720575 @default.
• W2023573903 cites W2161546495 @default.
• W2023573903 cites W2165090578 @default.
• W2023573903 cites W2167142486 @default.
• W2023573903 cites W240080621 @default.
• W2023573903 cites W4245483584 @default.
• W2023573903 doi "https://doi.org/10.1007/s00280-007-0660-z" @default.
• W2023573903 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5500182" @default.
• W2023573903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18175117" @default.
• W2023573903 hasPublicationYear "2008" @default.
• W2023573903 type Work @default.
• W2023573903 sameAs 2023573903 @default.
• W2023573903 citedByCount "12" @default.
• W2023573903 countsByYear W20235739032012 @default.
• W2023573903 countsByYear W20235739032013 @default.
• W2023573903 countsByYear W20235739032014 @default.
• W2023573903 countsByYear W20235739032016 @default.
• W2023573903 countsByYear W20235739032021 @default.
• W2023573903 crossrefType "journal-article" @default.
• W2023573903 hasAuthorship W2023573903A5014826195 @default.
• W2023573903 hasAuthorship W2023573903A5027648939 @default.
• W2023573903 hasAuthorship W2023573903A5031189811 @default.
• W2023573903 hasAuthorship W2023573903A5061684371 @default.
• W2023573903 hasBestOaLocation W20235739032 @default.
• W2023573903 hasConcept C104317684 @default.
• W2023573903 hasConcept C109316439 @default.
• W2023573903 hasConcept C111335760 @default.
• W2023573903 hasConcept C117262875 @default.
• W2023573903 hasConcept C138885662 @default.
• W2023573903 hasConcept C147897179 @default.
• W2023573903 hasConcept C150194340 @default.
• W2023573903 hasConcept C153911025 @default.
• W2023573903 hasConcept C161733203 @default.
• W2023573903 hasConcept C179926584 @default.
• W2023573903 hasConcept C185592680 @default.
• W2023573903 hasConcept C202751555 @default.
• W2023573903 hasConcept C2776924795 @default.
• W2023573903 hasConcept C41895202 @default.
• W2023573903 hasConcept C54009773 @default.
• W2023573903 hasConcept C54355233 @default.
• W2023573903 hasConcept C552990157 @default.
• W2023573903 hasConcept C55493867 @default.
• W2023573903 hasConcept C67705224 @default.
• W2023573903 hasConcept C86803240 @default.
• W2023573903 hasConceptScore W2023573903C104317684 @default.
• W2023573903 hasConceptScore W2023573903C109316439 @default.
• W2023573903 hasConceptScore W2023573903C111335760 @default.
• W2023573903 hasConceptScore W2023573903C117262875 @default.
• W2023573903 hasConceptScore W2023573903C138885662 @default.
• W2023573903 hasConceptScore W2023573903C147897179 @default.
• W2023573903 hasConceptScore W2023573903C150194340 @default.
• W2023573903 hasConceptScore W2023573903C153911025 @default.
• W2023573903 hasConceptScore W2023573903C161733203 @default.

• next